The Effects of Cannabidiol and ∆-9-THC in Humans



Status:Active, not recruiting
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 55
Updated:6/8/2018
Start Date:June 2010
End Date:July 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Cannabidiol Modulation of ∆-9-THC's Psychotomimetic Effects in Healthy Humans

Cannabis is the most commonly used illicit substance in the US and herbal cannabis consists
of a number of cannabinoids including Δ-9 THC and CBD. This study will characterize the
interactive effects of the two major components of cannabis i.e. Δ-9-THC and CBD.


Inclusion Criteria:

- Exposed to Cannabis at least once in lifetime

Exclusion Criteria:

- Cannabis Naive
We found this trial at
1
site
VA Connecticut Healthcare System
950 Campbell Ave
West Haven, Connecticut 06516
(203) 932-5711
Principal Investigator: Mohini Ranganathan, M.D.
Phone: 203-932-5711
VA Connecticut Healthcare System VA Connecticut encompasses an inpatient facility and Ambulatory Care Center in...
?
mi
from
West Haven, CT
Click here to add this to my saved trials